NEW: Interested in the issues we address in these blog posts? We’d be grateful if you completed our 6th App Developer Economics Survey. Click here to participate now!
Patients with chronic conditions remain the primary target group for mHealth app publishers, with diabetes management app solutions still considered the number one therapy field preference for developers.
With 2016 now in full swing and the launch of our 6th annual study into the global app market just around the corner, we’re reflecting on some of the key insights from our mHealth App Developer Economics Survey 2015, the largest global study of its kind, which garnered the insights of 5,000 experts active in the market.
In each survey we have conducted since 2010, diabetes has consistently been considered the therapy field offering the strongest business proposition for mHealth. In fact, according to our 2015 survey, 70% of mHealth practitioners rated diabetes highest for its market potential over the next five years.
With the leading publisher currently expecting to see global download figures of over 30,000 per quarter, the market has become increasingly competitive. Over 1,500 solutions are currently available to users, with leading developers opting for user-centric solutions with connected devices. Large corporate players are active in the market and are developing data-driven support tools. Device manufacturers are also beginning to adopt solutions that allow users to export data seamlessly.
If 2015 was the year we witnessed an acceleration in the development of interconnected D-devices, 2016 looks to be the year that device manufacturers compete with software developers in the market for tools that assist users in making smarter on-the-go decisions to achieve more effective glycaemic control. For a broader overview of some of these trends and developments, please see our Diabetes App Market Report.
From a diverse range of chronic conditions, the business potential preferences of mHealth app publishers haven’t changed in the past 5 years. In 2012, obesity management solutions were thought to rival diabetes management solutions for their potential, but our 2015 study shows that now just 38% of mHealth app practitioners rate obesity as the chronic disease with the highest business potential for mHealth apps. Hypertension (29%), depression (23%) and chronic heart diseases (16%) respectively have consistently ranked from third to fifth place in our rankings, with 2015 witnessing no change. The remaining chronic diseases (not shown in the chart above) will remain niche markets over the coming years according to mHealth experts.
To read more about this topic and for further insights into the current state of the mHealth App Economy , please download our free report, the 2015 mHealth App Developer Economics Study.
We welcome your feedback and actively encourage you to participate in this years’ App Developer Economics Survey which will launch in February 2016.